Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm Invitae has partnered with gene therapy developer Spark Therapeutics to launch a free genetic testing program for patients suspected of having inherited retinal disease (IRD).

In a separate deal, Invitae also partnered with X4 Pharmaceuticals to provide free genetic testing for WHIM syndrome and Severe Congenital Neutropenia (SCN), a group of rare inherited primary immunodeficiencies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.